TVIS44029882
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
23905799 |
23905799 |
q21.2 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030051
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
43391325 |
43391325 |
q22.3 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030061
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
20079710 |
20079710 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030095
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
20898356 |
20898356 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030102
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
28844099 |
28844099 |
q21.3 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030108
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
25976913 |
25976913 |
q21.3 |
APP |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030188
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
20127413 |
20127413 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030332
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
20846338 |
20846338 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030461
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
22533903 |
22533903 |
q21.1 |
- |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |
TVIS44030488
|
Human T-lymphotropic Virus |
HTLV-1c |
KF242506 |
- |
- |
hg18 |
21 |
17857919 |
17857919 |
q21.1 |
CHODL-AS1, ENSG00000305890 |
Nontumor |
Not given |
High throughput sequenicng |
30307560 |
2019 |
VISDB1.0 |